Abstract:Whole-genome sequencing (WGS) is increasingly favored over other genomic sequencing methods for clinical applications due to its comprehensive coverage and declining costs. WGS is particularly useful for the detection of copy number variants (CNVs), presumed to be more accurate than targeted sequencing assays such as WES or gene panels, because it can identify breakpoints in addition to changes in coverage depth. Recent advancements in bioinformatics tools, including those employing hardware acceleration and machine learning, have enhanced CNV detection. Although numerous benchmarking studies have been published, primarily focusing on open-source tools for short-read WGS CNV calling, systematic evaluations that encompass commercially available tools that meet the rigorous demands of clinical testing are still necessary. In clinical settings, where the confirmation of reported CNVs is often required, there is a higher priority on sensitivity over specificity/precision compared to research applications. Moreover, clinical gene panel reporting primarily concerns whether a CNV affects coding regions or, in some cases, promoters, rather than the precise detection of breakpoints. This study aims to benchmark the performance of various CNV detection tools tailored for clinical reporting from WGS using reference cell lines, providing insights critical for optimizing clinical diagnostics. Our results indicate that while different tools exhibit strengths in either sensitivity or precision and are better suited for certain classes and lengths of variants, few can deliver the balanced performance essential for clinical testing, where high sensitivity is imperative. Generally, callers demonstrate better performance for deletions than duplications, with the latter being poorly detected in events shorter than 5kb. We demonstrate that the DRAGEN™ v4.2 CNV caller, particularly with custom filters on its high sensitivity mode, offers a superior balance of sensitivity and precision compared to other available tools.

Evaluation of tools for identifying large copy number variations from ultra-low-coverage whole-genome sequencing data

Accuracy Of Cnv Detection From Gwas Data

An evaluation of copy number variation detection tools from whole-exome sequencing data.

A Single Cell Level Based Method For Copy Number Variation Analysis By Low Coverage Massively Parallel Sequencing

Pscc: Sensitive And Reliable Population-Scale Copy Number Variation Detection Method Based On Low Coverage Sequencing

Benchmarking of Germline Copy Number Variant Callers from Whole Genome Sequencing Data for Clinical Applications

Copy‐Number Variants Detection by Low‐Pass Whole‐Genome Sequencing

Comprehensive assessment of long-read sequencing platforms and calling algorithms for detection of copy number variation

Identification of copy number variants in whole-genome data using Reference Coverage Profiles

SeqCNV: a Novel Method for Identification of Copy Number Variations in Targeted Next-Generation Sequencing Data

Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data

Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.

Copy Number Variation Detection In Whole-Genome Sequencing Data Using The Bayesian Information Criterion

A Remark on Copy Number Variation Detection Methods

Comparative Studies of Copy Number Variation Detection Methods for Next-Generation Sequencing Technologies

Evaluation of Copy Number Variant Detection from Panel‐based Next‐generation Sequencing Data

High Detection Rate of Copy Number Variations Using Capture Sequencing Data: A Retrospective Study

CNV-TV: A Robust Method to Discover Copy Number Variation from Short Sequencing Reads

Evaluation of Somatic Copy Number Estimation Tools for Whole-Exome Sequencing Data

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

DL-CNV: A Deep Learning Method for Identifying Copy Number Variations Based on Next Generation Target Sequencing